SCHEMBL6537636

SCHEMBL6537636

CCOCc1c[nH]c2c([N+](=O)[O-])cccc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNA2 P51530 1/20 0.53
CASP6 P55212 1/20 0.53
CTDSP1 Q9GZU7 1/20 0.53
MAPT P10636 4/20 0.41
MAPK1 P28482 2/20 0.41
PARP1 P09874 1/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
FBP1 P09467 2/20 0.40
CLK1 P49759 2/20 0.40
DYRK1A Q13627 1/20 0.40
GSK3B P49841 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CLEC4M Q9H2X3 1/20 0.39
ALDH1A1 P00352 5/20 0.39
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537611 0.87 DNA2 (0.55) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL8472516 0.84 DNA2 (0.52) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6538006 0.81 DNA2 (0.68) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6537663 0.80 DNA2 (0.59) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6537609 0.80 DNA2 (0.55) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6537400 0.77 DNA2 (0.55) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6538228 0.77 DNA2 (0.47) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL4739348 0.76 CLEC4M (0.71) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6538267 0.76 DNA2 (0.63) DNA2CASP6CTDSP1MAPTMAPK1
SCHEMBL6538378 0.73 DNA2 (0.63) DNA2CASP6CTDSP1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed